The use of N- (4- (5-nitro-2-furyl) -2-thiazolyl) formamide in the study of bladder cancer
Tiltman, A.J.
South African Medical Journal 46(11): 293-294
1972
ISSN/ISBN: 0256-9574 PMID: 5018148 Document Number: 54619
Document emailed within 1 workday
Related Documents
Cohen, S.M.; Wittenberg, J.F.; Bryan, G.T. 1976: Effect of avitaminosis a and hypervitaminosis a on urinary bladder carcinogenicity of N-(4-(5-Nitro-2-furyl)-2-thiazolyl)formamide Cancer Research 36(7 Part 1): 2334-2339Rice, J.R.; Spry, L.A.; Zenser, T.V.; Davis, B.B. 1988: Effect of peroxidase inhibitors on an in vivo metabolite of the urinary bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats Cancer Research 48(2): 304-309
Cohen, S.M.; Zenser, T.V.; Murasaki, G.; Fukushima, S.; Mattammal, M.B.; Rapp, N.S.; Davis, B.B. 1981: Aspirin inhibition of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced lesions of the urinary bladder correlated with inhibition of metabolism by bladder prostaglandin endoperoxide synthetase Cancer Research 41(9 Part 1): 3355-3359
Sakata, T.; Hasegawa, R.; Johansson, S.L.; Zenser, T.V.; Cohen, S.M. 1986: Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide initiation and sodium saccharin promotion of urinary bladder carcinogenesis in male F344 rats Cancer Research 46(8): 3903-3906
Niell, H.B.; Wood, C.A.; Mickey, D.D.; Soloway, M.S. 1982: Time- and concentration-dependent inhibition of the clonogenic growth of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced murine bladder tumor cell lines by cis-diamminedichloroplatinum(II) Cancer Research 42(3): 807-811
Masui, T.; Mann, A.M.; Macatee, T.L.; Okamura, T.; Garland, E.M.; Fujii, H.; Pelling, J.C.; Cohen, S.M. 1991: H-ras mutations in rat urinary bladder carcinomas induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and sodium saccharin, sodium ascorbate, or related salts Cancer Research 51(13): 3471-3475
Zenser, T.V.; Mattammal, M.B.; Davis, B.B. 1980: Metabolism of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide by prostaglandin endoperoxide synthetase Cancer Research 40(1): 114-118
Morton, K.C.; Wang, C.Y. 1983: Enhanced macromolecular binding of N-[4-(5-nitro-2-furyl)-2-thiazolyl]- formamide in germfree versus conventional rats Cancer Research 43(8): 3628-3632
Ertürk, E.; Morris, J.E.; Cohen, S.M.; Price, J.M.; Bryan, G.T. 1970: Transplantable rat mammary tumors induced by 5-nitro-2-furaldehyde semicarbazone and by formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl] hydrazide Cancer Research 30(5): 1409-1412
Ertürk, E.; Morris, J.E.; Cohen, S.M.; Von Esch, A.M.; Crovetti, A.J.; Price, J.M.; Bryan, G.T. 1971: Comparative carcinogenicity of formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl]hydrazide and related chemicals in the rat Journal of the National Cancer Institute 47(2): 437-445
Mattammal, M.B.; Zenser, T.V.; Palmier, M.O.; Davis, B.B. 1985: Renal reduced nicotinamide adenine dinucleotide phosphate:cytochrome c reductase-mediated metabolism of the carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide Cancer Research 45(1): 149-156
Cohen, S.M.; Headley, D.B.; Bryan, G.T. 1973: The effect of adult thymectomy and adult splenectomy on the production of leukemia and stomach neoplasms in mice by N-(4-(5-nitro-2-furyl)-2-thiazolyl)acetamide Cancer Research 33(4): 637-640
Wise, R.W.; Zenser, T.V.; Davis, B.B. 1983: Peroxidase metabolism of the urinary bladder carcinogen 2-amino-4-(5-nitro-2-furyl)thiazole Cancer Research 43(4): 1518-1522
Holla, B.S.; Shivananda, M.K.; Akberali, P.M.; Baliga, S.; Safeer, S. 1996: Studies on arylfuran derivatives-Part VI. Synthesis, characterization and antibacterial activities of some 6-(5-aryl-2-furyl)-1,2,4-triazolo [3,4-b]-1,3,4-thiadiazoles and 6-(5-nitro-2-furyl)-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles Farmaco 51(12): 785-792
Tekeli, S.; Biava, C.G.; Price, J.M. 1973: The carcinogenic activity of 3-hydroxymethyl-1-((3-(5-nitro-2-furyl)allydidene)amino)-hydantoin in rats Cancer Research 33(11): 2894-2897
Tracy, J.W.; Catto, B.A.; Webster, L.T. 1991: Formation of N-(5-nitro-2-thiazolyl)-N'-carboxymethylurea from 5-hydroxyniridazole. Role of aldehyde dehydrogenase in the oxidative metabolism of niridazole Drug Metabolism and Disposition: the Biological Fate of Chemicals 19(2): 508-515
Mattammal, M.B.; Zenser, T.V.; Davis, B.B. 1981: Prostaglandin hydroperoxidase-mediated 2-amino-4-(5-nitro-2-furyl) [14C]thiazole metabolism and nucleic acid binding Cancer Research 41(12 Part 1): 4961-4966
Ertürk, E.; Cohen, S.M.; Bryan, G.T. 1970: Induction, histogenesis, and isotransplanta bility of renal tumors induced by formic acid 2-[4-(5-nitro-2-furyl)-2-triazolyl]-hydrazide in rats Cancer Research 30(8): 2098-2106
Mommsen, S.; Jakobsen, A.; Sell, A. 1989: Quality of life in patients with advanced bladder cancer. a randomized study comparing cystectomy and irradiation--the Danish Bladder Cancer Study Group (DAVECA protocol 8201) Scandinavian Journal of Urology and Nephrology. Supplementum 125: 115-120
Kotake, T.; Koyanagi, T.; Akaza, H.; Shimazaki, J.; Ito, H.; Hosaka, M.; Okajima, E.; Saito, Y.; Miyanaga, N.; Kuroda, M.; Hirao, Y. 1998: Results of clinical study with epirubicin hydrochloride injectable solution for superficial bladder cancer. IMI28 Injectable Solution Study Group for Superficial Bladder Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(8): 1189-1195